| Lymphoma by Site investigated in trials for …INVESTIGATED_IN_TRIALSderived131 of 131show fewer |
|---|
| → investigated in trials for | Rituximabmonoclonal antibody 98 trials (34 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 65 trials (26 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 53 trials (16 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 46 trials (16 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 40 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 38 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 26 trials (12 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 25 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 21 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 19 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 18 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 16 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 12 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bimiralisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tofacitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlormethinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daromun 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ropeginterferon Alfa-2bother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma by Site | 1 | Observed | clinicaltrials | graph → |